Hook & Thesis
Celestica reported a blowout Q1 and raised its full-year outlook, yet the stock has sold off sharply into that strength. That kind of reaction creates an asymmetric short-term opportunity: the business momentum is real - $4.05 billion in revenue in Q1 (up 53% year-over-year) and a raised guide to $19 billion in revenue and $10.15 in adjusted EPS - but sentiment has become overly defensive. I expect Celestica to post another beat-and-raise in the quarters ahead as hyperscaler and AI-related capex continues to lift server, storage and connectivity demand.
Trade idea: take a mid-term long position on the pullback. Entry $349.00, stop loss $320.00, target $420.00. This trade targets mean reversion into the company's improving fundamentals and room for multiple expansion as the market digests scale and cash flow improvements.
What Celestica Does and Why the Market Should Care
Celestica is a global provider of supply-chain and contract manufacturing solutions to equipment manufacturers and service providers, organized into Advanced Technology Solutions (ATS) and Connectivity and Cloud Solutions (CCS). The CCS business serves enterprise communications, telecommunications, servers and storage - the exact product categories that benefit from accelerated hyperscaler AI and cloud investments. Large hyperscalers and new entrants are driving a multi-year rebuild of data-center infrastructure, which flows through to Celestica as outsourcers and OEMs ramp capacity.
The macro tailwind is visible in industry coverage: recent reporting highlights hyperscalers' plans to spend hundreds of billions in infrastructure this year, and specific commitments by big AI players to multi-billion-dollar compute deals. For Celestica that means a revenue profile tilted to secularly growing, high-volume data-center hardware - a favorable mix shift compared with more cyclical industrial segments.
Fundamentals & Recent Performance
Key facts and recent prints drive the bullish case:
- Q1 revenue: $4.05 billion - up 53% YoY.
- Q1 adjusted EPS: $2.16, above the consensus in the quarter and management raised full-year guidance to $19.0 billion in revenue and $10.15 adjusted EPS (reported 04/27/2026).
- Market cap: about $39.7 billion with enterprise value roughly $40.1 billion.
- Valuation metrics: trailing P/E near 41x, P/S about 2.88x, EV/EBITDA roughly 29x.
- Profitability and balance sheet: return on equity is extremely healthy at ~45.7%, return on assets ~11.6%, and debt-to-equity is a modest 0.37.
- Free cash flow last reported: $491.5 million.
Operationally the story is scale + margin improvement. Revenue acceleration from CCS (server, storage, connectivity) is lifting top-line growth and leverage. Management's ability to raise guidance after a strong quarter tells us supply and backlog visibility are supportive, not constrained.
Valuation Framing
On a surface level the stock looks premium: the trailing P/E sits above 40x and P/B is near 19x. Those multiples reflect the market pricing in a multi-year growth profile tied to hyperscaler spending and a material improvement in ROE and free cash flow conversion. The logic for paying an elevated multiple is straightforward: if Celestica hits management's updated $19B revenue and $10.15 EPS guide, and if the company continues to convert revenue into free cash flow at scale, current multiples begin to look more reasonable.
Counterpoint: at today’s price near $348.63 the valuation leaves less margin for execution errors. But consider the enterprise value of ~$40.1B versus free cash flow of ~$491.5M; even modest improvements in FCF conversion would move valuation metrics. Historically the stock traded as high as $474.03 (52-week high on 06/02/2026) when sentiment was more exuberant around hyperscaler demand; the mid-cycle low was $153.11 (07/22/2025) reflecting the cyclical range. We are buying a recovery trade in the middle of that range with confirmed revenue acceleration and guide lifts.
Technical & Sentiment Context
Technical indicators show the stock is in a consolidation phase beneath its 50-day average (SMA 50: $376.57) and 20-day average (SMA 20: $362.12), with an RSI around 44.7. The MACD is modestly negative, indicating short-term momentum is muted, which is precisely why the recent pullback is tradable - downside appears limited relative to upside if fundamentals re-accelerate.
Short interest is not extreme: days-to-cover sits around 2 days in the latest readings, while short-volume data shows elevated short activity around recent down-days. That dynamic can amplify rebounds if an upside catalyst hits.
Catalysts
- Continued beat-and-raise cadence in coming quarterly reports - management already raised FY guidance after Q1 (reported 04/27/2026).
- Clear hyperscaler capex commitments from major cloud and AI players that translate into visible backlog for CCS products.
- Margin expansion from mix shift toward higher-margin, high-volume server and connectivity assemblies.
- Investor re-rating as revenue scales into the $15-20B range and free cash flow meaningfully improves.
Trade Plan (Actionable)
Entry: Buy at $349.00 (limit order). This is a near-current-price entry designed to capture a recovery into the 50-day moving average if fundamentals remain supportive.
Stop loss: $320.00. A breach below $320 would put price meaningfully below multi-week support and increase the risk of further downside.
Target: $420.00. This target assumes a rerating back toward more constructive sentiment and partial recovery toward recent highs; it also represents a sensible level to take profits on a mid-term rebound.
Horizon: Primary horizon is mid term (45 trading days). Expect the trade to play out over the next one to two months as sentiment normalizes and upcoming earnings or order-flow updates provide confirmation. If the company posts another beat-and-raise within that window, the trade should hit target quickly; otherwise, re-evaluate at monthly cadence. For traders wanting a longer hold, consider holding into the next two quarters (long term - 180 trading days) if cadence of beats continues.
Position Sizing & Risk Management
Given the valuation and potential for volatility around quarterly prints and macro headlines, size this trade such that the maximum portfolio loss at the stop is acceptable to you (recommendation: risk no more than 1-2% of portfolio equity per position). If the position moves in your favor, consider trimming into strength near $390-$400 and trim again at $420.
Risks & Counterarguments
- Execution risk: Celestica’s business mixes high-volume, low-margin OEM work with more technical, higher-margin projects. If execution or component constraints reappear, margins could compress and invalidate the re-rating thesis.
- Concentration risk from hyperscaler demand: A large portion of upside is tied to continued hyperscaler capex. If hyperscalers slow AI-related spending due to budget resets or cyclical weakness, revenue growth could decelerate rapidly.
- Valuation sensitivity: The stock currently trades at a premium multiple (P/E ~41x). Any miss in revenue or EPS would likely trigger outsized multiple compression.
- Macro / market risk: Broad risk-off moves or a rotation out of growth/tech names could push the stock lower even if Celestica’s fundamentals remain intact.
- Short-term volatility around prints: The market punished the stock after its last raised guide despite the beat, showing that sentiment can be fickle. Expect headline-driven whipsaw.
Counterargument: One could argue the recent multiple already prices in sustained hyperscaler strength and that any slowdown would expose the high valuation. That is a fair point: paying 40x+ earnings requires continued execution. This trade is structured as a mid-term recovery play rather than a long-term hold at today’s price; I want to see a second consecutive beat-and-raise or clearer backlog disclosure before adding size for a multi-quarter exposure.
Conclusion - What Would Change My Mind
Summary stance: tactically bullish. The Q1 beat and guide raise demonstrated that revenue and margin upside are real, and the pullback created an entry window. The trade is to buy the pullback into improving fundamentals with a mid-term (45 trading days) horizon, a defined stop at $320, and a target of $420.
What would change my mind: a meaningful guide cut or visible signs of order cancellations from hyperscaler customers; if FCF conversion stalls or management’s cadence of results weakens, I would exit the trade and reassess. Conversely, sustained beats and clearer, multi-year backlog disclosure would make me comfortable increasing size and extending the horizon to long term (180 trading days).
Key data snapshot
| Metric | Value |
|---|---|
| Current price | $348.63 |
| Market cap | $39.7B |
| Q1 revenue | $4.05B (53% YoY) |
| Q1 adjusted EPS | $2.16 |
| FY guide (raised) | $19.0B revenue / $10.15 EPS |
| Trailing P/E | ~41x |
| Free cash flow | $491.5M |
Trade smart: use a limit entry at $349.00, keep position size conservative given multiple risk, and watch incoming order-flow commentary and the next quarterly print for confirmation. If Celestica executes again, the upside to $420 is realistic within a 45-trading-day window; if not, the $320 stop protects capital and preserves optionality.